|
|
| HCN1_HUMAN |
HCN1 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 |
5.398e-31 |
0.30
|
| HCN4_HUMAN |
HCN4 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 |
1.752e-24 |
0.30
|
| ADA1A_HUMAN |
ADRA1A |
Alpha-1A adrenergic receptor |
8.173e-23 |
0.36
|
| ADA1B_HUMAN |
ADRA1B |
Alpha-1B adrenergic receptor |
1.428e-21 |
0.35
|
| SGMR2_RAT |
Tmem97 |
Sigma intracellular receptor 2 |
4.292e-21 |
0.34
|
| ADA1D_HUMAN |
ADRA1D |
Alpha-1D adrenergic receptor |
3.084e-19 |
0.36
|
| SGMR1_CAVPO |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
1.335e-18 |
0.35
|
| OPRM_RAT |
Oprm1 |
Mu-type opioid receptor |
3.664e-15 |
0.77
|
| OPRX_HUMAN |
OPRL1 |
Nociceptin receptor |
4.036e-12 |
0.53
|
| DCNL1_HUMAN |
DCUN1D1 |
DCN1-like protein 1 |
1.761e-11 |
0.30
|
| CALM_BOVIN |
CALM |
Calmodulin |
6.878e-11 |
0.29
|
| SCN2A_RAT |
Scn2a |
Sodium channel protein type 2 subunit alpha |
7.404e-11 |
0.31
|
| S12A5_RAT |
Slc12a5 |
Solute carrier family 12 member 5 |
1.52e-10 |
0.30
|
| CP74A_ARATH |
CYP74A |
Allene oxide synthase, chloroplastic |
3.619e-10 |
0.30
|
| NUAK1_HUMAN |
NUAK1 |
NUAK family SNF1-like kinase 1 |
3.625e-10 |
0.31
|
| OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
3.771e-10 |
0.77
|
| PDIA1_HUMAN |
P4HB |
Protein disulfide-isomerase |
7.004e-10 |
0.30
|
| OPRM_CAVPO |
OPRM1 |
Mu-type opioid receptor |
8.857e-10 |
0.77
|
| M3K15_HUMAN |
MAP3K15 |
Mitogen-activated protein kinase kinase kinase 15 |
9.209e-10 |
0.31
|
| ACM3_HUMAN |
CHRM3 |
Muscarinic acetylcholine receptor M3 |
4.731e-09 |
0.32
|
| KKCC2_HUMAN |
CAMKK2 |
Calcium/calmodulin-dependent protein kinase kinase 2 |
1.073e-08 |
0.31
|
| ERR3_MOUSE |
Esrrg |
Estrogen-related receptor gamma |
2.287e-08 |
0.30
|
| 5HT4R_RAT |
Htr4 |
5-hydroxytryptamine receptor 4 |
2.86e-08 |
0.32
|
| KCC4_HUMAN |
CAMK4 |
Calcium/calmodulin-dependent protein kinase type IV |
3.333e-08 |
0.31
|
| MAST1_HUMAN |
MAST1 |
Microtubule-associated serine/threonine-protein kinase 1 |
3.333e-08 |
0.31
|
| OXSR1_HUMAN |
OXSR1 |
Serine/threonine-protein kinase OSR1 |
3.333e-08 |
0.31
|
| STK39_HUMAN |
STK39 |
STE20/SPS1-related proline-alanine-rich protein kinase |
3.333e-08 |
0.31
|
| OPRD_HUMAN |
OPRD1 |
Delta-type opioid receptor |
6.475e-08 |
0.77
|
| MYO3B_HUMAN |
MYO3B |
Myosin-IIIb |
8.088e-08 |
0.31
|
| SBK3_HUMAN |
SBK3 |
Uncharacterized serine/threonine-protein kinase SBK3 |
1.767e-07 |
0.31
|
| SRPK2_HUMAN |
SRPK2 |
SRSF protein kinase 2 |
1.767e-07 |
0.31
|
| STK11_HUMAN |
STK11 |
Serine/threonine-protein kinase STK11 |
1.767e-07 |
0.31
|
| S1PR5_HUMAN |
S1PR5 |
Sphingosine 1-phosphate receptor 5 |
3.025e-07 |
0.33
|
| PRP4B_HUMAN |
PRPF4B |
Serine/threonine-protein kinase PRP4 homolog |
3.541e-07 |
0.31
|
| ACM4_RAT |
Chrm4 |
Muscarinic acetylcholine receptor M4 |
4.547e-07 |
0.30
|
| LATS1_HUMAN |
LATS1 |
Serine/threonine-protein kinase LATS1 |
6.604e-07 |
0.31
|
| SGK3_HUMAN |
SGK3 |
Serine/threonine-protein kinase Sgk3 |
6.604e-07 |
0.31
|
| LKHA4_HUMAN |
LTA4H |
Leukotriene A-4 hydrolase |
8.084e-07 |
0.32
|
| SC6A3_RAT |
Slc6a3 |
Sodium-dependent dopamine transporter |
8.493e-07 |
0.32
|
| ANM6_HUMAN |
PRMT6 |
Protein arginine N-methyltransferase 6 |
8.517e-07 |
0.31
|
| CDK18_HUMAN |
CDK18 |
Cyclin-dependent kinase 18 |
1.159e-06 |
0.31
|
| KCC1G_HUMAN |
CAMK1G |
Calcium/calmodulin-dependent protein kinase type 1G |
1.159e-06 |
0.31
|
| SBK1_HUMAN |
SBK1 |
Serine/threonine-protein kinase SBK1 |
1.159e-06 |
0.31
|
| STK24_HUMAN |
STK24 |
Serine/threonine-protein kinase 24 |
1.159e-06 |
0.31
|
| RIPK4_HUMAN |
RIPK4 |
Receptor-interacting serine/threonine-protein kinase 4 |
1.933e-06 |
0.31
|
| OPRM_MOUSE |
Oprm1 |
Mu-type opioid receptor |
1.975e-06 |
0.38
|
| Q63380_RAT |
NET |
Transporter |
2.213e-06 |
0.32
|
| HRH3_CAVPO |
HRH3 |
Histamine H3 receptor |
2.415e-06 |
0.31
|
| SGMR1_HUMAN |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
2.839e-06 |
0.31
|
| CILK1_HUMAN |
CILK1 |
Serine/threonine-protein kinase ICK |
3.082e-06 |
0.31
|
| INSRR_HUMAN |
INSRR |
Insulin receptor-related protein |
3.082e-06 |
0.31
|
| MYLK3_HUMAN |
MYLK3 |
Myosin light chain kinase 3 |
3.082e-06 |
0.31
|
| MYLK4_HUMAN |
MYLK4 |
Myosin light chain kinase family member 4 |
3.082e-06 |
0.31
|
| NR1I3_HUMAN |
NR1I3 |
Nuclear receptor subfamily 1 group I member 3 |
3.273e-06 |
0.29
|
| HRH1_CAVPO |
HRH1 |
Histamine H1 receptor |
3.555e-06 |
0.32
|
| CDK14_HUMAN |
CDK14 |
Cyclin-dependent kinase 14 |
4.73e-06 |
0.31
|
| LATS2_HUMAN |
LATS2 |
Serine/threonine-protein kinase LATS2 |
4.73e-06 |
0.31
|
| PI42B_HUMAN |
PIP4K2B |
Phosphatidylinositol 5-phosphate 4-kinase type-2 beta |
4.73e-06 |
0.31
|
| CCR5_MACFA |
CCR5 |
C-C chemokine receptor type 5 |
4.993e-06 |
0.28
|
| CP2J2_HUMAN |
CYP2J2 |
Cytochrome P450 2J2 |
5.557e-06 |
0.29
|
| OPRK_CAVPO |
OPRK1 |
Kappa-type opioid receptor |
6.275e-06 |
0.77
|
| CDK17_HUMAN |
CDK17 |
Cyclin-dependent kinase 17 |
7.02e-06 |
0.31
|
| M3K13_HUMAN |
MAP3K13 |
Mitogen-activated protein kinase kinase kinase 13 |
7.02e-06 |
0.31
|
| CA2D1_RAT |
Cacna2d1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 |
8.827e-06 |
0.29
|